AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 5.95 |
Market Cap | 21.80M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -2.64 |
PE Ratio (ttm) | -2.26 |
Forward PE | n/a |
Analyst | Buy |
Ask | 6.03 |
Volume | 4,770 |
Avg. Volume (20D) | 491,993 |
Open | 6.00 |
Previous Close | 5.90 |
Day's Range | 5.90 - 6.05 |
52-Week Range | 1.55 - 8.44 |
Beta | undefined |
About PULM
Pulmatrix, Inc., a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company focuses on developing products based on its inhaled small particles easily respirable and emitted (iSPERSE) technology, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It...
Analyst Forecast
According to 1 analyst ratings, the average rating for PULM stock is "Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.